MJ Biz reports
Health Canada will soon embark on a review of fees collected by the federal government from cannabis companies, including studying the impact those fees have on the industry as well as the policy goals of legalization.
“License holders will be engaged in this work over the coming months,” Health Canada spokeswoman Tammy Jarbeau told Marijuana Business Daily.
Health Canada’s planned review will be carried out in the upcoming fiscal year, which ends in March 2022, “to assess the impact of the cannabis fee structure on the policy goals of the Cannabis Act and on industry, as well as the progress made toward achieving full cost recovery,” she said.
Read the full article at
